Demonstrates rapid hemostasis in controlled models, suggesting a new biomaterial for effective bleeding control.
Current hemostatic materials often exhibit insufficient fluid absorption, poor mechanical stability, and limited tissue regenerative capacity. To overcome these limitations, this study proposed the concept of a capillary-driven hemostatic microenvironment. Through acid-enzymatic extraction of collagen from bovine hide (95.7% purity) and ion-exchange purification of carboxymethyl cellulose calcium (CMC-Ca) to enhance Ca²⁺ content, oriented porous collagen/CMC-Ca composite scaffolds were fabricated using directional freeze-drying technology to construct aligned microchannels. The composite exhibited excellent in vitro hemocompatibility with hemolysis rates < 3% and 40-60% accelerated coagulation. In vivo evaluations using SD rat tail amputation and liver hemorrhage models demonstrated that the optimal formulation (Col@2.5%CMC-Ca) achieved rapid hemostasis (tail: 120 ± 11 s, 0.49 ± 0.05 g blood loss; liver: 24.3 ± 8.7 s, 0.1 ± 0.08 g blood loss), reducing blood loss by 52-86% compared to commercial controls. Furthermore, the scaffold promoted liver regeneration, showing significant tissue repair at 14 days post-implantation. This study establishes a dual-functional biomaterial integrating rapid hemostasis with proactive tissue repair, offering a promising solution to overcome existing limitations in hemostatic materials.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: